AP4 and AP5 precise mechanisms are yet to be defined and therefore pathways involved in known diseases linked to their deficiency such as HSP or Alzheimer’s disease is yet to be identified. Here, AP5B1 is linked to early-onset autosomal dominant Alzheimer disease.